T829-0820 Screening compound: ethyl 1-{2-methyl-5-[(4-methylphenyl)methyl]-4H,5H,6H,7H-furo[3,2-c]pyridine-3-carbonyl}piperidine-4-carboxylate

T829-0820 Screening compound: ethyl 1-{2-methyl-5-[(4-methylphenyl)methyl]-4H,5H,6H,7H-furo[3,2-c]pyridine-3-carbonyl}piperidine-4-carboxylate
T829-0820 Screening compound: ethyl 1-{2-methyl-5-[(4-methylphenyl)methyl]-4H,5H,6H,7H-furo[3,2-c]pyridine-3-carbonyl}piperidine-4-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound T829-0820
ethyl 1-{2-methyl-5-[(4-methylphenyl)methyl]-4H,5H,6H,7H-furo[3,2-c]pyridine-3-carbonyl}piperidine-4-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T829-0820

Molecular Formula

C25H32N2O4 (C25 H32 N2 O4)

Compound Name

ethyl 1-{2-methyl-5-[(4-methylphenyl)methyl]-4H,5H,6H,7H-furo[3,2-c]pyridine-3-carbonyl}piperidine-4-carboxylate

IUPAC name

ethyl 1-{2-methyl-5-[(4-methylphenyl)methyl]-4H5H6H7H-furo[32-c]pyridine-3-carbonyl}piperidine-4-carboxylate

SMILES

CCOC(C(CC1)CCN1C(c1c(C)oc2c1CN(Cc1ccc(C)cc1)CC2)=O)=O

InChI

InChI=1S/C25H32N2O4/c1-4-30-25(29)20-9-13-27(14-10-20)24(28)23-18(3)31-22-11-12-26(16-21(22)23)15-19-7-5-17(2)6-8-19/h5-8,20H,4,9-16H2,1-3H3

InChI Key

FPPOMFYDVZWDFD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28995031

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

424.54

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.428

Distribution Coefficient, logD

-1.848

Water Solubility, LogSw

-3.45

Polar Surface Area

49.262

Acid Dissociation Constant (pKa)

23.24

Base Dissociation Constant (pKb)

12.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.00

T829-0820 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

CNS BBB Library (22607 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Hemic and lymphatic
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T829-0820 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T829-0820?
Check Price and Availability of T829-0820, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T829-0820 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T829-0820
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T829-0820
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T829-0820 available by request